749 related articles for article (PubMed ID: 16086755)
21. Influence of treatment of erosive lichen planus of the vulva on its prognosis.
Cooper SM; Wojnarowska F
Arch Dermatol; 2006 Mar; 142(3):289-94. PubMed ID: 16549703
[TBL] [Abstract][Full Text] [Related]
22. Long-term management of facial atopic eczema with pimecrolimus cream 1% in paediatric patients with mild to moderate disease.
Zuberbier T; Bräutigam M
J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):718-21. PubMed ID: 18312323
[TBL] [Abstract][Full Text] [Related]
23. Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study.
Gribetz C; Ling M; Lebwohl M; Pariser D; Draelos Z; Gottlieb AB; Zaias N; Chen DM; Parneix-Spake A; Hultsch T; Menter A
J Am Acad Dermatol; 2004 Nov; 51(5):731-8. PubMed ID: 15523351
[TBL] [Abstract][Full Text] [Related]
24. Facial actinic lichen planus following the Blaschko's lines: successful treatment with topical 0.1% pimecrolimus cream.
Ezzedine K; Simonart T; Vereecken P; Heenen M
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):458-9. PubMed ID: 18624870
[No Abstract] [Full Text] [Related]
25. Topical pimecrolimus: a new horizon for vitiligo treatment?
Sendur N; Karaman G; Saniç N; Savk E
J Dermatolog Treat; 2006; 17(6):338-42. PubMed ID: 17853306
[TBL] [Abstract][Full Text] [Related]
26. Treatment of erosive oral lichen planus with topical tacrolimus.
Thomson MA; Hamburger J; Stewart DG; Lewis HM
J Dermatolog Treat; 2004 Sep; 15(5):308-14. PubMed ID: 15370399
[TBL] [Abstract][Full Text] [Related]
27. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption.
Chu CY
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):484-90. PubMed ID: 17373975
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: results of a randomized, double-blind, vehicle-controlled study.
Dawid M; Veensalu M; Grassberger M; Wolff K
J Dtsch Dermatol Ges; 2006 Nov; 4(11):942-6. PubMed ID: 17081269
[TBL] [Abstract][Full Text] [Related]
29. Two cases of Zoon's balanitis treated with pimecrolimus 1% cream.
Bardazzi F; Antonucci A; Savoia F; Balestri R
Int J Dermatol; 2008 Feb; 47(2):198-201. PubMed ID: 18211499
[TBL] [Abstract][Full Text] [Related]
30. Pimecrolimus 1% cream for anogenital lichen sclerosus in childhood.
Boms S; Gambichler T; Freitag M; Altmeyer P; Kreuter A
BMC Dermatol; 2004 Oct; 4(1):14. PubMed ID: 15485581
[TBL] [Abstract][Full Text] [Related]
31. Pimecrolimus for the treatment of vulvar lichen sclerosus: a report of 4 cases.
Goldstein AT; Marinoff SC; Christopher K
J Reprod Med; 2004 Oct; 49(10):778-80. PubMed ID: 15568399
[TBL] [Abstract][Full Text] [Related]
32. Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus.
Hengge UR; Krause W; Hofmann H; Stadler R; Gross G; Meurer M; Brinkmeier T; Frosch P; Moll I; Fritsch P; Müller K; Meykadeh N; Marini A; Ruzicka T; Gollnick H
Br J Dermatol; 2006 Nov; 155(5):1021-8. PubMed ID: 17034535
[TBL] [Abstract][Full Text] [Related]
33. The safety and efficacy of pimecrolimus, 1%, cream for the treatment of Netherton syndrome: results from an exploratory study.
Yan AC; Honig PJ; Ming ME; Weber J; Shah KN
Arch Dermatol; 2010 Jan; 146(1):57-62. PubMed ID: 20083693
[TBL] [Abstract][Full Text] [Related]
34. Topical pimecrolimus 1% cream for resistant seborrheic dermatitis of the face: an open-label study.
Ozden MG; Tekin NS; Ilter N; Ankarali H
Am J Clin Dermatol; 2010; 11(1):51-4. PubMed ID: 20000875
[TBL] [Abstract][Full Text] [Related]
35. Pimecrolimus 1% cream for the treatment of steroid-induced rosacea: an 8-week split-face clinical trial.
Lee DH; Li K; Suh DH
Br J Dermatol; 2008 May; 158(5):1069-76. PubMed ID: 18363758
[TBL] [Abstract][Full Text] [Related]
36. Pimecrolimus cream 1% in the treatment of lichen sclerosus.
Nissi R; Eriksen H; Risteli J; Niemimaa M
Gynecol Obstet Invest; 2007; 63(3):151-4. PubMed ID: 17085943
[TBL] [Abstract][Full Text] [Related]
37. Safety and tolerability of 1% pimecrolimus cream among infants: experience with 1133 patients treated for up to 2 years.
Paul C; Cork M; Rossi AB; Papp KA; Barbier N; de Prost Y
Pediatrics; 2006 Jan; 117(1):e118-28. PubMed ID: 16361223
[TBL] [Abstract][Full Text] [Related]
38. A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis.
Kempers S; Boguniewicz M; Carter E; Jarratt M; Pariser D; Stewart D; Stiller M; Tschen E; Chon K; Wisseh S; Abrams B
J Am Acad Dermatol; 2004 Oct; 51(4):515-25. PubMed ID: 15389185
[TBL] [Abstract][Full Text] [Related]
39. Treatment of oral lichen planus with topical pimecrolimus 1% cream.
Esquivel-Pedraza L; Fernández-Cuevas L; Ortíz-Pedroza G; Reyes-Gutiérrez E; Orozco-Topete R
Br J Dermatol; 2004 Apr; 150(4):771-3. PubMed ID: 15099380
[No Abstract] [Full Text] [Related]
40. An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo.
Stinco G; Piccirillo F; Forcione M; Valent F; Patrone P
Eur J Dermatol; 2009; 19(6):588-93. PubMed ID: 19651562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
